ProMIS Neurosciences Inc

Research ProMIS Neurosciences Inc (PMN) on Bullrun: market cap USD 96.40M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPMN
• ExchangeNASDAQ
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 96.40M
• Financial periodFY2025
• Net income-USD 39.72M

Valuation Snapshot

latest market cap is USD 96.40M.

About ProMIS Neurosciences Inc

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis;

Frequently asked questions

What is ProMIS Neurosciences Inc's market cap?

ProMIS Neurosciences Inc's market capitalization is USD 96.40M.

What does ProMIS Neurosciences Inc do?

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.